» Articles » PMID: 39959845

Chronic Airflow Limitation, Lower Respiratory Symptoms, COPD and Chronic Rhinosinusitis in a Middle-Aged Population: The Swedish CArdioPulmonary BioImage Study (SCAPIS). A Link Between the Lower and Upper Airways

Abstract

Purpose: Chronic rhinosinusitis (CRS) is related to asthma and chronic obstructive pulmonary disease (COPD). However, combined data on CRS, pulmonary function, lower airway symptoms, and cigarette smoking from the general population are lacking. The current study investigates the relationships between CRS and chronic airflow limitation (CAL), lower airway symptoms and COPD in a middle-aged population of ever-smokers and never-smokers.

Patients And Methods: All subjects from the Swedish CArdioPulmonary bioImage Study (SCAPIS) were included. Subjects underwent spirometry after bronchodilation. Chronic airflow limitation was defined as FEV/FVC ratio <0.7. Computed tomography imaging of the thorax was performed to detect the presence of emphysema, and the subjects answered a comprehensive questionnaire on CRS, lower airway symptoms, asthma, chronic bronchitis, and cigarette smoking habits.

Results: In total, 30,154 adult subjects in the age range of 50-64 years were included. The prevalence of CRS was 5.6%. CRS was more-prevalent among subjects in the following categories: CAL (7.6%), lower airway symptoms (15.7%), current smokers (8.2%), asthma (13.6%), never-smokers and ever-smokers with COPD (17.6% and 15.3%, respectively), emphysema (6.7%), and chronic bronchitis (24.5%). In the adjusted regression model, CRS was significantly associated with CAL (OR 1.40), lower airway symptoms (OR 4.59), chronic bronchitis (OR 6.48), asthma (OR 3.08), and COPD (OR 3.10).

Conclusion: In this national, randomly chosen population sample of more than 30,000 middle-aged men and women, CRS is associated with CAL, lower airway symptoms, chronic bronchitis, asthma, and COPD. In patients with CRS and in patients with lower airway inflammation, it is important to consider the inflammatory status of the entire airway system.

References
1.
Divo M, Liu C, Polverino F, Castaldi P, Celli B, Tesfaigzi Y . From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator. Eur Respir J. 2023; 62(3). PMC: 10533946. DOI: 10.1183/13993003.00806-2023. View

2.
Fokkens W, Lund V, Hopkins C, Hellings P, Kern R, Reitsma S . European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020; 58(Suppl S29):1-464. DOI: 10.4193/Rhin20.600. View

3.
Bonander C, Nilsson A, Bjork J, Blomberg A, Engstrom G, Jernberg T . The value of combining individual and small area sociodemographic data for assessing and handling selective participation in cohort studies: Evidence from the Swedish CardioPulmonary bioImage Study. PLoS One. 2022; 17(3):e0265088. PMC: 8903292. DOI: 10.1371/journal.pone.0265088. View

4.
Bergqvist J, Andersson A, Olin A, Murgia N, Schioler L, Bove M . New evidence of increased risk of rhinitis in subjects with COPD: a longitudinal population study. Int J Chron Obstruct Pulmon Dis. 2016; 11:2617-2623. PMC: 5079701. DOI: 10.2147/COPD.S115086. View

5.
Toren K, Brisman J, Jarvholm B . Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest. 1993; 104(2):600-8. DOI: 10.1378/chest.104.2.600. View